.

COMAC MEDICAL AMONG GROWTH CHAMPIONS ACCORDING TO IMP³ROVE

Comac Medical has conducted an assessment in IMP³rove – an instrument provided by the European Commission for measurement of the innovation potential of the company, which ranked the company among the Growth champions in Europe. This valuable indication of the SME competitive position, shows the positive innovation management performance of COMAC Medical Ltd., which is the same with the Growth Champions, with overall score of 58% in a benchmarking class of all countries and above the average score of 54%.

The European Innovation Management Academy – IMP³rove executes international comparative analysis of SMEs and uses a holistic approach to the assessment of innovation management as a key driver for competitiveness.

The sustainable and profitable growth as a result of innovation management of Comac Medical is benchmarked along the following five key dimensions:

  • Innovation strategy
  • Innovation organisation and culture
  • Innovation life-cycle management
  • Innovation enabling factors
  • Innovation results
The detailed IMP³rove Benchmarking report creates a baseline for the company’s competitiveness, revealing the strengths and weaknesses in innovation management.

The IMP³rove Assessment report from October 19, 2015, which is a valuable indication of the SME competitive position, shows the positive innovation management performance of Comac Medical, which is the same with the Growth Champions, with overall score of 58% in a benchmarking class of all countries and above the average score of 54%.

IMP³rove – European Innovation Management Academy is perceived world-wide as the “knowledge hub” that continuously and significantly contributes to the wealth and competitiveness in Europe and beyond.

For more information, please see: https://www.improve-innovation.eu/